Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid

被引：0

作者：

Brufau-Cochs, Magi ^{[1
]}

Alamon-Reig, Francesc ^{[1
]}

Luque-Luna, Mar ^{[1
]}

Bosch-Amate, Xavier ^{[1
]}

Moreta, Maria Jose ^{[2
]}

Bassegoda, Octavi ^{[2
]}

Mascaro Jr, Jose M. ^{[1
,3
]}

机构：

[1] Univ Barcelona, Hosp Clin Barcelona, Dept Dermatol, Barcelona, Spain

[2] Univ Barcelona, Hosp Clin Barcelona, Liver ICU, Barcelona, Spain

[3] Hosp Clin Barcelona, Dept Dermatol, C Villarroel 170, Barcelona 08036, Spain

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2024年 / 22卷 / 03期

关键词：

Bull & ouml; ses Pemphigoid; blasenbildende Hauterkrankungen; bull & ouml; ses Pemphigoid des & Ouml; sophagus; Dipeptidyl-Peptidase-4-Inhibitor; Gliptine; Bullous pemphigoid; dipeptidyl-peptidase; 4; inhibitor; esophageal bullous pemphigoid; gliptins; skin blistering diseases;

D O I：

10.1111/ddg.15304_g

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：432 / 433

页数：2

共 13 条

[1] ANTI-INTERCELLULAR SUBSTANCE ANTIBODIES - PRESENCE IN SERUM SAMPLES OF 14 PATIENTS WITHOUT PEMPHIGUS
AHMED, AR
WORKMAN, S
[J]. ARCHIVES OF DERMATOLOGY, 1983, 119 (01) : 17 - 21
[2] Late-onset 'sloughing esophagitis' (esophagitis dissecans superficialis) associated with bullous pemphigoid
Carolina Morel-Cerda, Eliana
Adrian Priego-Parra, Bryan
Grube-Pagola, Peter
Maria Remes-Troche, Jose
[J]. BMJ CASE REPORTS, 2020, 13 (07)
[3] Castelo Branco Catarina, 2022, Eur J Case Rep Intern Med, V9, P003160, DOI 10.12890/2022_003160
[4] Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin
Chouchane, Karim
Di Zenzo, Giovanni
Pitocco, Dario
Calabrese, Laura
De Simone, Clara
[J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
[5] S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid
Hofmann, Silke C.
Guenther, Claudia
Boeckle, Barbara C.
Didona, Dario
Ehrchen, Jan
Gaskins, Matthew
Geerling, Gerd
Glaeser, Regine
Hadaschik, Eva
Hampl, Monika
Hasskamp, Pia
Jackowski, Jochen
Kiritsi, Dimitra
Nast, Alexander
Pleyer, Uwe
Reichel, Christoph
Roth, Mathias
Schumann, Michael
Sticherling, Michael
Worm, Margitta
Zillikens, Detlef
Goebeler, Matthias
Schmidt, Enno
[J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (11): : 1530 - 1550
[6] Holtsche MM, 2023, J DTSCH DERMATOL GES, V21, P405, DOI 10.1111/ddg.15046
[7] Case of bullous pemphigoid associated with teneligliptin accompanied by severe mucous membrane involvement
Kage, Yuta
Yamaguchi, Yukie
Uchida, Takahisa
Izumi, Kentaro
Nishie, Wataru
Shimizu, Hiroshi
Ishii, Norito
Hashimoto, Takashi
Aihara, Michiko
[J]. JOURNAL OF DERMATOLOGY, 2018, 45 (07) : E205 - E206
[8] Drug-induced pemphigoid: Clinical presentation, diagnosis, and management of gliptin-associated cicatrizing conjunctivitis
Kate, Anahita
Doctor, Mariya B.
Basu, Sayan
[J]. OCULAR SURFACE, 2022, 26 : 50 - 52
[9] Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes Estimating the Risk of the New Agents and Characterizing the Patients
Kridin, Khalaf
Bergman, Reuven
[J]. JAMA DERMATOLOGY, 2018, 154 (10) : 1152 - 1158
[10] Oesophageal involvement in bullous pemphigoid
Maharshak, N.
Sagi, M.
Santos, E.
Sprecher, E.
Goldberg, I.
[J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (03) : 274 - 275

← 1 2 →